(Q24240701)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091557%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

1 reference

title

Treatment for Barrett's oesophagus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091557%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091557%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Pierre Lao-Sirieix

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091557%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Angela Wong

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091557%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Rebecca C Fitzgerald

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091557%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

20 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091557%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091557%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091557%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

CD004060

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091557%20AND%20SRC:MED&resulttype=core&format=json

Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Randomized trial of argon plasma coagulation versus endoscopic surveillance for barrett esophagus after antireflux surgery: late results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Chemoprevention for Barrett's esophagus trial. Design and outcome measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Radiofrequency ablation in Barrett's esophagus with dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett's esophagus after antireflux surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Persistent acid reflux and symptoms in patients with Barrett's oesophagus on proton-pump inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Clinical and histologic follow-up after antireflux surgery for Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

KTP laser ablation of Barrett's esophagus after anti-reflux surgery results in long-term loss of intestinal metaplasia. Potassium-titanyl-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Acid suppression therapy may not alter malignant progression in Barrett's metaplasia showing p53 protein accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Early and late results of the acid suppression and duodenal diversion operation in patients with barrett's esophagus: analysis of 210 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Surgical therapy for Barrett's esophagus: prevention, protection and excision

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Argon plasma coagulation therapy for ablation of Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Intestinal metaplasia in the distal esophagus and correlation with symptoms of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Short esophagus: analysis of predictors and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Barrett’s Esophagus Can and Does Regress After Antireflux Surgery: A Study of Prevalence and Predictive Features

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Molecular evaluation of ablative therapy of Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Timing of 5-aminolaevulinic acid-induced photodynamic therapy for the treatment of patients with Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Long-term outcome of antireflux surgery in patients with Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorin): a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Cryoablation of Barrett's esophagus: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Laparoscopic antireflux surgery: disease-related quality of life assessment before and after surgery in GERD patients with and without Barrett's esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Nissen fundoplication for reflux esophagitis. Long-term clinical and endoscopic results in 109 of 127 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Ablation of nonneoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Photodynamic diagnosis of gastrointestinal precancerous lesions after sensitization with 5-aminolevulinic acid. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Endoscopic ablation of Barrett's esophagus using argon plasma coagulation (APC) following surgical laparoscopic fundoplication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Glutathione peroxidase isoforms as part of the local antioxidative defense system in normal and Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

The economic impact of the diagnosis of dysplasia in Barrett's esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

New alternatives in the management of gastroesophageal reflux disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Chromoendoscopy with methylene blue and associated DNA damage in Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Observer variation in the diagnosis of superficial oesophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Time gated fluorescence spectroscopy in Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Barrett's esophagus: combined treatment using argon plasma coagulation and laparoscopic antireflux surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Gastroesophageal reflux, quality of life, and satisfaction in patients with achalasia treated with open cardiomyotomy and partial fundoplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Increased DNA adducts in Barrett's esophagus and reflux-related esophageal malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Esophagectomy for adenocarcinoma in patients 45 years of age and younger

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Does the addition of a prokinetic to proton pump inhibitor therapy help reduce duodenogastro-oesophageal reflux in patients with Barrett's oesophagus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Effects of long-term treatment with proton pump inhibitors in gastro-oesophageal reflux disease on the histological findings in the lower oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Barrett's esophagus with high grade dysplasia: surgical results and long-term outcome--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Endoscopic mucosal resection of premalignant lesions of the upper gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Photodynamic therapy in Barrett's esophagus: results of treatment of 17 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Dietary antioxidants and DNA damage in patients on long-term acid-suppression therapy: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Detection of Barrett's epithelium by acoustic microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

A randomized trial of aspirin to prevent colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Mortality study of 18 000 patients treated with omeprazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Retinoic acid-induced glandular differentiation of the oesophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Aberrant arachidonic acid metabolism in esophageal adenocarcinogenesis, and the effects of sulindac, nordihydroguaiaretic acid, and alpha-difluoromethylornithine on tumorigenesis in a rat surgical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Antireflux surgery for Barrett's esophagus: comparative results of the Nissen and Collis-Nissen operations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Bexarotene and erlotinib for aerodigestive tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Photodynamic therapy using 5-aminolaevulinic acid for the treatment of dysplasia in Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Retinoids in cancer therapy and chemoprevention: promise meets resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

An antiapoptotic role for gastrin and the gastrin/CCK-2 receptor in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

The surgical option for gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Surgical therapy for Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Acid and bile salts induce DNA damage in human oesophageal cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Quantitative endoscopy: precise computerized measurement of metaplastic epithelial surface area in Barrett's esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Effect of acid suppression on molecular predictors for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Prospective trial of laparoscopic nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: Seven-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Adenocarcinoma of the rat esophagus in the presence of a proton pump inhibitor: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

High-energy laser therapy of Barrett's esophagus: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Photodynamic therapy for Barrett's esophagus: cardiac effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Heartburn requiring frequent antacid use may indicate significant illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Prevalence of Barrett's esophagus in the general population: an endoscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Experimental Evidence for Mutagenic Potential of Duodenogastric Juice on Barrett’s Esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Proton pump inhibitors for Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Review article: long-term use of proton pump inhibitors in GORD--help or hindrance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Complications of open and laparoscopic antireflux surgery: 32-year audit at a teaching hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Endoscopic therapy for Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Effects of long-term cyclo-oxygenase 2 selective and acid inhibition on Barrett’s oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004060.PUB2

Immunohistological study of cell cycle-related factors, oncogene expression, and cell proliferation in adenocarcinoma developed in Barrett's esophagus

21 January 2018

1 reference

12 December 2020

Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus

1 reference

12 December 2020

Reflux and Barrett's oesophagitis after gastric surgery--long-term follow-up and implications for the roles of gastric acid and bile in oesophagitis

1 reference

12 December 2020

Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients

1 reference

12 December 2020

Endoscopic ablative therapy for Barrett's esophagus: current status

1 reference

12 December 2020

Resection and advancement of esophageal mucosa. A potential therapy for Barrett's esophagus

1 reference

12 December 2020

Oesophagectomy for early adenocarcinoma and dysplasia arising in Barrett's oesophagus

1 reference

12 December 2020

Late results of a randomized clinical trial comparing total fundoplication versus calibration of the cardia with posterior gastropexy

1 reference

12 December 2020

Endoscopic surveillance of Barrett's esophagus. Does it help?

1 reference

12 December 2020

Continuous treatment with omeprazole 20 mg daily for up to 6 years in Barrett's oesophagus

1 reference

12 December 2020

Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective?

1 reference

12 December 2020

Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery

1 reference

12 December 2020

Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities

1 reference

12 December 2020

Barrett's esophagus control after antireflux surgery

1 reference

12 December 2020

Losses of heterozygosity on chromosomes 9p and 17p are frequent events in Barrett's metaplasia not associated with dysplasia or adenocarcinoma.

1 reference

12 December 2020

Morbidity of laparoscopic fundoplication for gastroesophageal reflux: a retrospective study about 1470 patients

1 reference

12 December 2020

Conservative treatment versus antireflux surgery in Barrett's oesophagus: long-term results of a prospective study

1 reference

12 December 2020

5-Aminolevulinic acid photosensitization of dysplastic Barrett's esophagus: a pharmacokinetic study.

1 reference

12 December 2020

Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus

1 reference

12 December 2020

Surgery or endotherapy for high-grade dysplasia/early adenocarcinoma in Barrett's oesophagus?

1 reference

12 December 2020

Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus

1 reference

12 December 2020

Failure of Nd-YAG photocoagulation therapy as treatment for Barrett's oesophagus--a pilot study.

1 reference

12 December 2020

Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial

1 reference

12 December 2020

Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases

1 reference

12 December 2020

Progression or regression of Barrett's esophagus--is it all in the eye of the beholder?

1 reference

12 December 2020

Barrett's oesophagus: results from a 13-year surveillance programme.

1 reference

12 December 2020

Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): current clinical and development status

1 reference

12 December 2020

Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation

1 reference

12 December 2020

[Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma]

1 reference

12 December 2020

Surgical treatment of the non-complicated gastroesophageal reflux: fundoplication without division of the short gastric vessels

1 reference

12 December 2020

When fundoplication fails: redo?

1 reference

12 December 2020

Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery

1 reference

12 December 2020

ECP-EURONUT study of diet and intestinal metaplasia. ECP-EURONUT-IM Study Group

1 reference

12 December 2020

Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux

1 reference

12 December 2020

[Laparoscopic fundoplication in the treatment of Barrett esophagus]

1 reference

12 December 2020

Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma

1 reference

12 December 2020

Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett esophagus

1 reference

12 December 2020

Results of surgical treatment for recurrent postoperative gastroesophageal reflux

1 reference

12 December 2020

Photodynamic therapy of Barrett's esophagus: ablation of Barrett's mucosa and reduction in p53 protein expression after treatment.

1 reference

12 December 2020

A COX-2 inhibitor suppresses esophageal inflammation-metaplasia-adenocarcinoma sequence in rats

1 reference

12 December 2020

Barrett esophagus: ablative methods of treatment

1 reference

12 December 2020

Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus

1 reference

12 December 2020

Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus

1 reference

12 December 2020

Barrett's esophagus: Macroscopic markers and the prediction of dysplasia and adenocarcinoma

1 reference

12 December 2020

Outcomes of laparoscopic antireflux procedures

1 reference

12 December 2020

Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia

1 reference

12 December 2020

Rabeprazole for the prevention of pathologic and symptomatic relapse of erosive or ulcerative gastroesophageal reflux disease. Rebeprazole Study Group

1 reference

12 December 2020

Esophageal dysmotility in patients undergoing photodynamic therapy

1 reference

12 December 2020

Buried dysplasia and early adenocarcinoma arising in barrett esophagus after porfimer-photodynamic therapy

1 reference

12 December 2020

Healing and relapse of severe peptic esophagitis after treatment with omeprazole

1 reference

12 December 2020

Barrett's esophagus: results of a multicentric survey. G.O.S.P.E. (Gruppo Operativo per lo Studio delle Precancerosi Esofagee

1 reference

12 December 2020

Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia

1 reference

12 December 2020

Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression

1 reference

12 December 2020

Rising incidence of adenocarcinoma of the esophagus and gastric cardia

1 reference

12 December 2020

EUS characteristics of Nissen fundoplication: normal appearance and mechanisms of failure

1 reference

12 December 2020

Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease

1 reference

12 December 2020

Photodynamic therapy of dysplasias and early carcinomas in Barrett esophagus with a diode laser system--a pilot study

1 reference

12 December 2020

Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus

1 reference

12 December 2020

The retinoic acid paradox in cancer chemoprevention

1 reference

12 December 2020

Preoperative chemotherapy unmasks underlying Barrett's mucosa in patients with adenocarcinoma of the distal esophagus

1 reference

12 December 2020

Endoscopic treatment of Barrett's epithelium with Argon Plasma Coagulation. Long-term follow-up

1 reference

12 December 2020

Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings

1 reference

12 December 2020

Managing Barrett's oesophagus

1 reference

12 December 2020

Barrett's esophagus: age, prevalence, and extent of columnar epithelium

1 reference

12 December 2020

Outcomes of dysplasia arising in Barrett's esophagus: a dynamic view

1 reference

12 December 2020

Endoscopic spray cryotherapy: a new technique for mucosal ablation in the esophagus

1 reference

12 December 2020

Gastrointestinal tissue polyamine contents of patients with Barrett's esophagus treated with alpha-difluoromethylornithine.

1 reference

12 December 2020

Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus

1 reference

12 December 2020

10.1002/14651858.CD004060.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

5011114

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20091557%20AND%20SRC:MED&resulttype=core&format=json

OpenCitations bibliographic resource ID

17 January 2020

5011114

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

5011114

1 reference